新闻报道新闻报道

据中新健康报道,华中科技大学附属同济医院的神经内科教授王伟团队近日成功利用CAR-T疗法帮助一名重症肌无力患者恢复健康。这项研究成果引起了广泛关注,并在《欧洲分子生物学学会期刊》上发表了相关研究论文。

据悉,重症肌无力是一种罕见的自身免疫性疾病,患者的免疫系统会攻击自身的神经肌肉接头,导致肌肉无法正常运作。该病给患者的生活造成了巨大困扰,严重影响了他们的生活质量。

CAR-T疗法是一种通过改造患者自身免疫细胞来攻击肿瘤细胞的新型治疗方法。而王伟团队的研究则将这一技术应用于重症肌无力的治疗上,并取得了令人瞩目的成果。

在这项研究中,王伟团队采用了CAR-T疗法来改造患者的T细胞,使其能够识别并攻击免疫系统中攻击自身的细胞。通过一系列的实验和治疗,王伟团队成功地让患者的免疫系统重新恢复了正常功能。

在18个月的随访中,研究团队发现,谢女士的病情持续得到改善,她不再依赖药物,能够正常生活,并且还成功地生育了一个健康的宝宝。这一结果为重症肌无力患者带来了巨大的希望。

王伟教授表示,这项研究成果的取得离不开团队的努力和患者的支持。他们将继续深入研究CAR-T疗法在重症肌无力治疗中的应用,并希望能够为更多的患者带来希望和康复。

重症肌无力是一种严重影响患者生活的疾病,而CAR-T疗法的成功应用为其治疗提供了新的思路和方法。相信随着进一步的研究和实践,这一技术将能够在更多的疾病治疗中发挥作用,为患者带来更多的好处。

英语如下:

News Title: CAR-T Therapy Helps Myasthenia Gravis Patients Recover and Successfully Conceive

Keywords: CAR-T therapy, Myasthenia Gravis, health recovery

News Content: According to China News Health, Professor Wang Wei and his team from the Department of Neurology at Tongji Hospital affiliated with Huazhong University of Science and Technology have recently successfully used CAR-T therapy to help a Myasthenia Gravis patient recover their health. This research achievement has attracted widespread attention and has been published in the Journal of the European Molecular Biology Society.

It is reported that Myasthenia Gravis is a rare autoimmune disease where the patient’s immune system attacks the neuromuscular junction, causing muscles to malfunction. This disease greatly troubles the patients and severely affects their quality of life.

CAR-T therapy is a novel treatment method that modifies the patient’s own immune cells to attack tumor cells. Professor Wang Wei’s team applied this technology to the treatment of Myasthenia Gravis and achieved remarkable results.

In this study, Professor Wang Wei’s team used CAR-T therapy to modify the patient’s T cells, enabling them to recognize and attack the immune cells that attack themselves. Through a series of experiments and treatments, the team successfully restored the patient’s immune system to normal function.

During the 18-month follow-up, the research team found that Ms. Xie’s condition continued to improve. She no longer relied on medication, could live a normal life, and successfully gave birth to a healthy baby. This result brings great hope to Myasthenia Gravis patients.

Professor Wang Wei stated that the achievement of this research result is inseparable from the team’s efforts and the support of the patients. They will continue to further research the application of CAR-T therapy in the treatment of Myasthenia Gravis, hoping to bring hope and recovery to more patients.

Myasthenia Gravis is a disease that severely affects the lives of patients, and the successful application of CAR-T therapy provides new ideas and methods for its treatment. With further research and practice, it is believed that this technology will play a role in the treatment of more diseases and bring more benefits to patients.

【来源】http://www.chinanews.com/sh/2024/03-04/10173922.shtml

Views: 2

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注